Click here to view this email on your mobile device
View this email in your Web browser: http://whatcounts.jobson.com/dm?id=%%SUBSCRIBER_ID_TAG%%
December 04, 2014
VMail Technology
www.visionmonday.com   Facebook Twitter
In This Edition

SYSTEMS / EQUIPMENT

Icare Intros Puff-less Tonometer

EXAMS / DISPENSING

Eyetek’s DAS (Digital Acuity System)
Konan Intros EvokeDx

SYSTEMS / EQUIPMENT

New Tonometer is Puff-less and Patient-friendly


Product: Icare Rebound Tonometer
Top Line: The Icare Rebound Tonometer is designed for glaucoma detection and control. It makes the IOP measuring routine quick, effortless and effective, according to Icare.
Close Up: No anesthetic or disinfection is needed. As a result, the patient flow can be kept dynamic even with massive screening programs. The Icare tonometer's disposable probe touches the cornea very lightly for only a fraction of a second.
The measurement is barely noticeable by the patient and therefore suitable even for non-compliant subjects, such as children and dementia patients.
Icare has worldwide official approvals (CE, U.S. FDA, SFDA etc.) and satisfied users in over 50 countries. Clinical studies show that the data obtained by Icare is fully comparable to measuring results obtained with the GAT.
Vital Stats:

  • No calibration, anesthetic or air puff 4 AA batteries (good for 12 months)
  • Easy to use and proven to be accurate, repeatable and patient friendly.
  • Used by prestigious ophthalmology departments such as Wills Eye Hospital, Cleveland Clinic, Duke, Johns Hopkins.
www.icare-usa.com; (888) 422-7313


Top Send your comments to VM

EXAMS / DISPENSING

Eyetek Intros Versatile Acuity Testing System


Product: DAS (Digital Acuity System)
Top Line: Eyetek’s new DAS (Digital Acuity System) uses the latest in advanced and affordable technology. A computer, the size of a pack of gum, plugs directly into the HDMI of an LCD TV. A rechargeable handset uses only nine buttons to perform the same tasks as 30-button systems that cost almost two-and-a-half times as much. Everything needed to start using the system is provided.
Close Up:
Standard tests include:
  • Snellen, children, E's, numbers, contrast
  • Single line occlusion
  • Single line
  • Single letter Snellen and child
  • Color test
  • Red/green overlay
  • Aux tests, fixation, astig. wheel, Worth 4 dot
  • Educational videos, or add your own movies
  • Photo gallery or add your own photos
  • Wi-fi with web browsing
  • Unlimited apps available on the Android store.
Vital Stats: Made and supported in the US. $895, less in quantities. Flat rate, next day service $89, after warranty.
www.eyeimg.com; (800) 323-4382

For more on Diagnostic Instruments and Testing, visit VM’s Intelligent Office

Top Send your comments to VM

Konan Medical Introduces EvokeDx, a Next Generation VEP + ERG Vision Diagnostics Platform


More Images
Product: EvokeDx
Top Line: Konan Medical is launching its newest device, EvokeDx, a next-generation visual pathway diagnostics platform to assess visual evoked potentials (VEP) and electroretinograms (ERG).
Close Up: VEPs are vision-produced, electrophysiological signals recorded near the brain’s visual cortex. EvokeDx provides highly quantitative, objective measures of visual function. ERG signals are used to differentially assess retina-specific dysfunction, reflecting the integrity of the eye’s optics, photoreceptors, bipolar cells and retinal ganglion cells, providing a limited assessment of the visual pathway.
icVEP is the patented, isolated-check stimulus and analysis strategy that was the subject of an NIH-sponsored, multi-center clinical trial at five prestigious US sites and two international locations to rapidly and objectively assess glaucomatous damage. “In the NIH-sponsored trials, our icVEP strategy had a classification accuracy of 89 to 94 percent,” said Vance Zemon, PhD, a professor at Yeshiva University, Albert Einstein College of Medicine Campus and co-inventor of EvokeDx. A glaucoma diagnostic indication based upon this data was recently granted for the icVEP strategy in China. EvokeDx is FDA 510(k) cleared and the CE Mark is anticipated the first half of 2015 (an application for glaucoma diagnostic indication has not yet been submitted to FDA for review).
Vital Stats: EvokeDx features include patented test strategies that are designed to isolate and test various visual pathways and visual functions, with Fourier-transform frequency analysis methods, and an all-in-one design incorporating a state of the art organic LED stimulus display and an automated gaze tracking system that helps ensure patients are fixated correctly during the procedure. Synchronized data collection combined with proprietary analysis of the entire EEG waveform provides detailed information about visual pathway function not available with previous generation devices.
www.KonanMedical.com; (949) 521-7730

For more on Diagnostic Instruments and Testing, visit VM’s Intelligent Office

Top Send your comments to VM

BACK TO TOP

Send Us Your News & Ideas

Andrew Karp, Group Editor, Lenses and Technology

Send us news about developments in dispensing technology, lens processing equipment, software, diagnostic and web technology. Or provide us with subjects for future stories or topics you'd like to see covered. Contact VMail Technology’s Editor Andrew Karp at akarp@jobson.com.


VMail Technology is a service of Jobson Medical Information LLC, the publisher of VisionMonday®,
440 Ninth Ave, 14th Floor, New York NY 10001.

If you do not wish to receive future VMail Technology e-mails, please click UNSUBSCRIBE.

© 2018 Jobson Medical Information LLC All Rights Reserved EyesWay content is developed, sourced and
reported by the editors of EyesWay, the international news portal. VMail provides that content to its
subscribers as part of an exclusive news exchange agreement.